期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
中心复合设计法制备盐酸奈福泮微孔渗透泵控释片 被引量:5
1
作者 武晓景 刘薇娜 +3 位作者 王晶 石晓磊 姚慧敏 李三鸣 《沈阳药科大学学报》 CAS CSCD 北大核心 2009年第11期863-867,共5页
目的以盐酸奈福泮为模型药物制备微孔渗透泵,控制其在24 h内维持零级释放,且最终释药量达90%以上。方法采用中心复合设计法优化处方。以24 h累计释药量和释药速率为考察指标对包衣膜PEG-400含量和包衣膜厚度2个自变量进行多元线性回归... 目的以盐酸奈福泮为模型药物制备微孔渗透泵,控制其在24 h内维持零级释放,且最终释药量达90%以上。方法采用中心复合设计法优化处方。以24 h累计释药量和释药速率为考察指标对包衣膜PEG-400含量和包衣膜厚度2个自变量进行多元线性回归和二项式拟合,并进行预测分析。结果2个影响因素和2个评价指标之间存在定量关系,优化处方各指标的预测值和目标值接近。结论经中心复合设计优化的盐酸奈福泮微孔渗透泵片能24 h零级释药。 展开更多
关键词 盐酸奈福泮 微孔渗透泵片 中心复合设计 控释释放
下载PDF
多孔微晶玻璃作为药物载体材料的制备及其体外释药研究 被引量:14
2
作者 王德平 黄文旵 陈天丹 《无机材料学报》 SCIE EI CAS CSCD 北大核心 2001年第6期1195-1198,共4页
应用玻璃结晶法制备了以磷酸钙为主体的多孔微晶玻璃载体材料,并以利福平作为 模型药物进行了体外释药试验.研究表明该载体材料能够在高浓度水平下长期维持药物的稳定 释放;研究结果还显示调节磷酸钙纤维的几何尺寸可以有效地改变载... 应用玻璃结晶法制备了以磷酸钙为主体的多孔微晶玻璃载体材料,并以利福平作为 模型药物进行了体外释药试验.研究表明该载体材料能够在高浓度水平下长期维持药物的稳定 释放;研究结果还显示调节磷酸钙纤维的几何尺寸可以有效地改变载体材料的空隙率,因此有 望成为一种理想的 DDS(Drug delivery system)药物控释性释放的新型无机载体材料. 展开更多
关键词 生物微晶玻璃 药物载体 缓释作用 药物 控释释放 制备 显微结构 体外释药
下载PDF
有序介孔二氧化硅FDU-12载非诺贝特双层渗透泵片的研究 被引量:1
3
作者 朱梦迪 《中南药学》 CAS 2018年第7期939-943,共5页
目的利用FDU-12提高难溶性药物非诺贝特(FNB)的溶出速率,并结合双层渗透泵技术实现药物的恒速释放。方法用吸附法将FNB载入FDU-12的有序介孔孔道中形成载药体系FNB-FDU-12。通过粉末X射线衍射法(PXDR)和傅里叶红外光谱法(FTIR)对介孔孔... 目的利用FDU-12提高难溶性药物非诺贝特(FNB)的溶出速率,并结合双层渗透泵技术实现药物的恒速释放。方法用吸附法将FNB载入FDU-12的有序介孔孔道中形成载药体系FNB-FDU-12。通过粉末X射线衍射法(PXDR)和傅里叶红外光谱法(FTIR)对介孔孔道中FNB的存在状态进行表征。利用体外溶出实验对双层渗透泵片的处方组成进行筛选。结果通过表征结果证明,药物FNB是以无定型形式存在于载体FDU-12介孔孔道中。体外溶出实验表明,FDU-12能明显提高FNB溶出速率,双层渗透泵技术能使药物实现控释释放。结论有序介孔二氧化硅材料FDU-12和双层渗透泵技术的结合能显著改善FNB的溶出速率,并实现难溶性药物的恒速释放。 展开更多
关键词 非诺贝特 FDU-12 吸附法 双层渗透泵 控释释放
下载PDF
盐酸地尔硫择时释放渗透泵控释片在犬体内的药动学研究
4
作者 尹飞 董江南 +1 位作者 杨星钢 潘卫三 《中国药房》 CAS CSCD 2014年第1期22-24,共3页
目的:研究盐酸地尔硫择时释放渗透泵控释片在犬体内的药动学特征,并进行体内外相关性评价。方法:以市售盐酸地尔硫缓释胶囊为参比制剂,采用双周期双交叉实验设计。选用6只Beagle犬分别灌服参比制剂或受试制剂(盐酸地尔硫择时释放渗透泵... 目的:研究盐酸地尔硫择时释放渗透泵控释片在犬体内的药动学特征,并进行体内外相关性评价。方法:以市售盐酸地尔硫缓释胶囊为参比制剂,采用双周期双交叉实验设计。选用6只Beagle犬分别灌服参比制剂或受试制剂(盐酸地尔硫择时释放渗透泵控释片)120 mg,于给药前和给药后1、2、3、4、6、7、8、9、10、12、14、16、24、36、48 h取前肢静脉血3 ml。采用反相高效液相色谱法测定盐酸地尔硫的血药浓度,以DAS 2.0软件计算药动学参数,以体内吸收百分数(y)对体外累计释放百分率(x)进行线性回归评价体内外相关性。结果:受试制剂和参比制剂的药动学参数t1/2分别为(12.00±3.65)、(8.30±2.16)h,tmax分别为(18.00±4.73)、(5.00±1.79)h,cmax分别为(169.27±67.48)、(137.80±8.20)ng/ml,AUC0-48 h分别为(2 929.91±719.21)、(2 597.06±578.09)ng·h/ml,生物利用度为(121.8±50.3)%,体内外相关性回归方程为y=1.429 7x+7.114(r=0.988 6)。结论:盐酸地尔硫择时释放渗透泵控释片具有缓释效果,且体内外相关性较好,但其体内时滞时间过长。 展开更多
关键词 盐酸地尔硫革 择时释放渗透泵控释 BEAGLE犬 药动学 体内外相关性
原文传递
单硝酸异山梨酯择时释放渗透泵控释片的研制.Ⅰ.星点设计-效应面法优化处方 被引量:5
5
作者 邹青 王柏 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第5期449-453,共5页
基于渗透泵原理,通过在单层渗透泵片芯外包隔离衣和控释衣,研制具有4 h时滞、零级释药特性并能完全释药的单硝酸异山梨酯择时释放渗透泵控释片。以控释衣增重量、控释衣中致孔剂含量、隔离衣增重比例和片芯中渗透压促进剂含量为考察因... 基于渗透泵原理,通过在单层渗透泵片芯外包隔离衣和控释衣,研制具有4 h时滞、零级释药特性并能完全释药的单硝酸异山梨酯择时释放渗透泵控释片。以控释衣增重量、控释衣中致孔剂含量、隔离衣增重比例和片芯中渗透压促进剂含量为考察因素,4和16 h的累积释放率和累积释放率-时间方程的线性系数为优化指标,应用星点设计-效应面法优化处方。结果显示,时滞的长短主要由控释衣和隔离衣的水化共同决定。所得优化处方在不同pH值介质中均存在4 h时滞(4 h累积释放率<10%),16 h累积释放率>90%,释药动力主要是渗透压。 展开更多
关键词 单硝酸异山梨酯 择时释放渗透泵控释 制备 时滞 星点设计 效应面法
原文传递
pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment 被引量:8
6
作者 Ke-Ni Yang Chun-Qiu Zhang +3 位作者 Wei Wang Paul C.Wang Jian-Ping Zhou Xing-Jie Liang 《Cancer Biology & Medicine》 SCIE CAS CSCD 2014年第1期34-43,共10页
In the fight against cancer, controlled drug delivery systems have emerged to enhance the therapeutic efficacy and safety of anti-cancer drugs. Among these systems, mesoporous silica nanoparticles (MSNs) with a func... In the fight against cancer, controlled drug delivery systems have emerged to enhance the therapeutic efficacy and safety of anti-cancer drugs. Among these systems, mesoporous silica nanoparticles (MSNs) with a functional surface possess obvious advantages and were thus rapidly developed for cancer treatment. Many stimuli-responsive materials, such as nanopartides, polymers, and inorganic materials, have been applied as caps and gatekeepers to control drug release from MSNs. This review presents an overview of the recent progress in the production of pH-responsive MSNs based on the pH gradient between normal tissues and the tumor microenvironment. Four main categories of gatekeepers can respond to acidic conditions. These categories will be described in detail. 展开更多
关键词 Mesoporous silica nanoparticles PH-RESPONSIVE controlled drug release drug delivery systems antineoplastic protocols
下载PDF
Preparation of Bovine Serum Albumin Microspheres by an Acetone-ethanol Heat Denaturation Method
7
作者 何琳 陈国强 +1 位作者 路英杰 陈金春 《Journal of Chinese Pharmaceutical Sciences》 CAS 1997年第2期28-35,共8页
Stable sub 500 nm bovine serum albumin (BSA) microsphere suspensions were produced by controlled addition of acetone and ethanol to an aqueous solution of BSA, followed by stabilization process of the formed microsphe... Stable sub 500 nm bovine serum albumin (BSA) microsphere suspensions were produced by controlled addition of acetone and ethanol to an aqueous solution of BSA, followed by stabilization process of the formed microspheres at an elevated temperature. Microspheres produced by this acetone ethanol heat denaturation method were stabilized at relatively low temperatures (70~75℃) over a short period of time (20 min). The acetone ethanol heat denaturation method, in comparison with the traditional oil/ water technique for preparation of albumin microspheres, which requires high temperature (over 100℃) and longer heating time (more than 30 min) for stabilization, offers a number of advantages. This report describes the influence of process conditions, such as ratios of acetone to ethanol to BSA aqueous solution, heating time and heating temperature, on microsphere formation and their stability. A loading efficiency of 40% rose bengal was achieved. Rose bengal release rates from these microspheres in phosphate buffered saline medium at 37 ℃ were dependent on microsphere stabilities and 25% to 60% of initial loading drug were released in 15 days. 展开更多
关键词 Bovine serum albumin Microsphere manufacture Protein denaturation Rose bengal Release study MICROENCAPSULATION
全文增补中
Hydroxy Propyl Methyl Cellulose: Different Aspects in Drug Delivery
8
作者 Tamasree Majumder Gopa Roy Biswas Sutapa Biswas Majee 《Journal of Pharmacy and Pharmacology》 2016年第8期381-385,共5页
Among the various research works going on nowadays, designing of controlled release dosage form is of great importance. For the development of suitable controlled release dosage form, a proper matrix needs to be forme... Among the various research works going on nowadays, designing of controlled release dosage form is of great importance. For the development of suitable controlled release dosage form, a proper matrix needs to be formed from which the drug release generally occur by polymer swelling, polymer erosion, drug dissolution/diffusion mechanism. HPMC (hydroxy propyl methyl cellulose), also known as hypromellose, is one of the best known cellulosic polymers used in the development of controlled released drug delivery. It is available in various grades. Cellulosic polymers are ingredients that contain units linked together which help to retain water. Due to its high water absorptive capacity, it acts as an excellent hydrophilic gel forming polymer. HPMC generally hydrates on the outer surface to form a gelatinous layer which is critical to prevent wetting and rapid drug release from the matrices. If the drug is sparingly soluble in the system, the release of drug from the system is slow and helps in formulation of controlled release dosage form. In the ophthalmic dosage form, HPMC is used as a matrix that swells and expands after absorbing water and expand the thickness of the tear film. 展开更多
关键词 HPMC HYPROMELLOSE HYDROPHILIC controlled released dosage form.
下载PDF
药物释放系统研究进展 被引量:3
9
作者 章航宇 陈燕 +1 位作者 吕慧侠 周建平 《药学进展》 CAS 2013年第7期289-295,共7页
我国的药物释放系统研究取得长足进步。通过检索2011年我国学者在国内外期刊上发表的高水平研究论文,发现热点主要集中在纳米释药系统、缓控释药物释放系统和经皮释药系统的研究。
关键词 纳米释药系统 控释药物释放系统 经皮释药系统
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部